CIK 0001267565
- Large accelerated filer
COLLEGIUM PHARMACEUTICAL, INC
Sign in to watch- Ticker
- COLL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- Phone
- +1 781-713-3699
- Business address
- 100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA, 02072
- Former names
- COLLEGIUM PHARMACEUTICAL INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-03 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −46,417 | $40.36 | $1.9M | 75,329 |
| 2026-03-03 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −3,559 | $40.99 | $146K | 71,770 |
| 2026-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +19,023 | 122,636 | ||
| 2026-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Grant or award | +30,702 | 153,338 | ||
| 2026-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −9,977 | $46.75 | $466K | 143,361 |
| 2026-02-10 | Dreyer Scott EVP & Chief Commercial Officer | Shares withheld for taxes | −21,615 | $46.75 | $1.0M | 121,746 |
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Exercise or conversion 10b5-1 | +17,600 | $15.90 | $280K | 121,213 |
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −11,125 | $47.89 | $533K | 110,088 |
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −6,475 | $48.66 | $315K | 103,613 |
| 2025-12-08 | Dreyer Scott EVP & Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Purchase) 10b5-1 | −17,600 | 0 | ||
| 2025-08-18 | Dreyer Scott EVP & Chief Commercial Officer | Exercise or conversion 10b5-1 | +16,389 | $21.34 | $350K | 120,002 |
| 2025-08-18 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −16,389 | $38.21 | $626K | 103,613 |
| 2025-08-18 | Dreyer Scott EVP & Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Purchase) 10b5-1 | −16,389 | 0 | ||
| 2025-08-13 | Dreyer Scott EVP & Chief Commercial Officer | Exercise or conversion 10b5-1 | +4,861 | $21.34 | $104K | 108,474 |
| 2025-08-13 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −4,861 | $38.03 | $185K | 103,613 |
| 2025-08-13 | Dreyer Scott EVP & Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Purchase) 10b5-1 | −4,861 | 16,389 | ||
| 2025-03-21 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −18,881 | $30.03 | $567K | 103,613 |
| 2025-03-20 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −1,927 | $30.00 | $58K | 122,494 |
| 2025-03-14 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −2,255 | $30.00 | $68K | 124,421 |
| 2025-03-11 | Dreyer Scott EVP & Chief Commercial Officer | Sale 10b5-1 | −15,387 | $30.00 | $462K | 126,676 |
Page 1 of 5 · 84 trades